Curis (CRIS) Receives USPTO Notice of Allowance for HDAC and PDK-Focused Compounds Patent
Tweet Send to a Friend
Curis (NASDAQ: CRIS) is active early Tuesday after the company announced the receipt of a Notice of Allowance of a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
